An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast

AB Gottlieb, B Strober, JG Krueger… - … medical research and …, 2008 - Taylor & Francis
Objective: To evaluate the clinical and biological activity of apremilast in patients with severe
plaque-type psoriasis. Research design and methods: Apremilast, a phosphodiesterase‑4 …
被引用次数：151 相关文章

An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast.

AB Gottlieb, B Strober, JG Krueger… - Current Medical …, 2008 - europepmc.org
Objective To evaluate the clinical and biological activity of apremilast in patients with severe
plaque-type psoriasis. Research design and methods Apremilast, a phosphodiesterase-4 …

[引用][C] An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast

AB Gottlieb, B Strober, JG Krueger, P Rohane… - … Medical Research and …, 2008 - cir.nii.ac.jp
An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated
with an oral anti-inflammatory agent, apremilast | CiNii Research CiNii 国立情報学研究所 学術 …

An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast

AB Gottlieb, B Strober, JG Krueger… - Current medical …, 2008 - pubmed.ncbi.nlm.nih.gov
Objective To evaluate the clinical and biological activity of apremilast in patients with severe
plaque-type psoriasis. Research design and methods Apremilast, a phosphodiesterase-4 …

An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast

AB Gottlieb, B Strober, JG Krueger… - Current Medical …, 2008 - search.proquest.com
OBJECTIVE: To evaluate the clinical and biological activity of apremilast in patients with
severe plaque-type psoriasis. RESEARCH DESIGN AND METHODS: Apremilast, a …

[引用][C] An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast

AB GOTTLIEB, B STROBER, JG KRUEGER… - … medical research and …, 2008 - Informa